Harte-Hanks Inc. Stock Upgraded (HHS)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Harte-Hanks (NYSE: HHS) has been upgraded by TheStreet Ratings from sell to hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Highlights from the ratings report include:
  • The current debt-to-equity ratio, 0.34, is low and is below the industry average, implying that there has been successful management of debt levels. Along with the favorable debt-to-equity ratio, the company maintains an adequate quick ratio of 1.36, which illustrates the ability to avoid short-term cash problems.
  • Net operating cash flow has increased to $35.35 million or 31.78% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of -6.31%.
  • HARTE HANKS INC reported flat earnings per share in the most recent quarter. The company has reported a trend of declining earnings per share over the past two years. However, the consensus estimate suggests that this trend should reverse in the coming year. During the past fiscal year, HARTE HANKS INC swung to a loss, reporting -$1.16 versus $0.69 in the prior year. This year, the market expects an improvement in earnings ($0.63 versus -$1.16).
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Media industry. The net income has significantly decreased by 27.4% when compared to the same quarter one year ago, falling from $14.73 million to $10.70 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Media industry and the overall market, HARTE HANKS INC's return on equity significantly trails that of both the industry average and the S&P 500.
.

Harte-Hanks, Inc., a direct and targeted marketing company, provides direct and digital marketing services, and shopper advertising opportunities to a range of local, regional, national, and international consumer and business-to-business marketers in the United States and other countries. Harte-Hanks has a market cap of $471.7 million and is part of the services sector and media industry. Shares are up 28.5% year to date as of the close of trading on Monday.

You can view the full Harte-Hanks Ratings Report or get investment ideas from our investment research center.

-- Written by a member of TheStreet Ratings Staff

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

What To Sell: 3 Sell-Rated Dividend Stocks HHS, CMFN, KRO

3 Sell-Rated Dividend Stocks: HHS, FSFR, NRP

3 Sell-Rated Dividend Stocks: HHS, AMTG, VET

What To Sell: 3 Sell-Rated Dividend Stocks HHS, AMTG, ACSF

3 Sell-Rated Dividend Stocks: HHS, RIGP, HMLP